Harmon Cyrus
Transaction: 07/24/2026
SELL
Change
-12,500
Price
$11.71
Filing
07/27/2026
Type
SELL
Olema Pharmaceuticals, Inc.
OLMA • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$911.03M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 9.95Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$911.03M
52W Range5.13 - 36.26
Beta2.01
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio9.95
Quick Ratio9.95
Target$31.00
Price$0.00
Change0.00%
Market Cap$911.03M
52W Range5.13 - 36.26
Beta2.01
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio9.95
Quick Ratio9.95
Target$31.00
Target Median$35.00
Target Range20.00 - 38.00
Volume2.67M
Avg Volume1.26M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
65/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 9.95Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$20.00
Mean
$31.00
Median
$35.00
High
$38.00
Insider Transactions
Recent executive and insider activity
Harmon Cyrus
Transaction: 07/23/2026
SELL
Change
-12,500
Price
$11.58
Filing
07/27/2026
Type
SELL
Graham G. Walmsley
Transaction: 06/18/2026
BUY
Change
+29,500
Price
$9.51
Filing
06/23/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Harmon Cyrus | SELL | -12,500 | $11.71 | 07/24/2026 | 07/27/2026 |
| Harmon Cyrus | SELL | -12,500 | $11.58 | 07/23/2026 | 07/27/2026 |
| Graham G. Walmsley | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| RAPPAPORT ANDREW | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Raman Prakash | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Horning Sandra | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Larson Yi | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| CLARK IAN T | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Hrustanovic Gorjan | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Garland J. Scott | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| BUTITTA CYNTHIA M | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Harmon Cyrus | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| BVF PARTNERS L P/IL | BUY | +29,500 | $9.51 | 06/18/2026 | 06/23/2026 |
| Raman Prakash | OTHER | 0 | Not reported | 04/28/2026 | 04/29/2026 |
| Raman Prakash | BUY | +2,911 | $14.59 | 04/28/2026 | 04/29/2026 |
| Mitchell Shawnte | SELL | -233 | $24.69 | 03/04/2026 | 03/05/2026 |
| Mitchell Shawnte | SELL | -24,767 | $24.25 | 03/04/2026 | 03/05/2026 |
| Mitchell Shawnte | SELL | -25,000 | $4.37 | 03/04/2026 | 03/05/2026 |
| Mitchell Shawnte | SELL | -15,000 | $23.01 | 03/03/2026 | 03/05/2026 |
| Mitchell Shawnte | SELL | -15,000 | $4.37 | 03/03/2026 | 03/05/2026 |